The automation of clinical trials has been an ongoing evolution, and one that benefits the collection of trial and study management data. Over the past decade, the industry has eliminated many manual processes, such as the handling of paper case report forms and the time-consuming process of double data entry with electronic data capture. In fact, an industry report suggests the clinical trial technology sector could top $5 billion by 2018, especially as globalization, outsourcing of clinical trial processes and trial complexity continue to increase. With each advance in technology, clinical trial sponsors and contract research organizations enjoy ever-finer degrees of transparency over all aspects of study execution. However, even with all of these improvements, there are still major pockets of manual processes within clinical development that need to be automated.